In celebration of the recent re-launch of our aguulp for biome probiotic supplement, we thought it was only appropriate to take a closer look at our powerful supplement, mainly the ten different probiotic strains packed inside it.
This expert series looks at each strain found in our much-loved supplement, giving you a better understanding of what makes this product stand out in the market (without bragging, of course).
What are probiotics?
Probiotics are friendly live bacteria and yeasts that provide health benefits to our overall health. They are predominantly found in the digestive system but can also be found in the urinary & reproductive systems and on the skin. They are made up of a genus, species and a strain, and are all very different.
Probiotics can be taken in supplement form, and they can also be found in fermented foods and drinks, and dairy products.
What is the role of probiotics?
Probiotics play a crucial role in our digestive system but also to our overall health. They help to control the growth and levels of harmful and pathogenic bacteria, helping prevent infections.
Probiotics not only ensure optimal gut health but also help your body absorb essential vitamins like B & K2, helping to boost your energy, support brain function, and bone strength. They also break down certain carbs and fibres into short-chain fatty acids (SCFAs), – exerting anti-inflammatory effects in -the —- body.
That’s not all, a huge body of evidence has shown that probiotics extend their benefits beyond the gut. From enhancing your skin’s radiance to supercharging your immune system, supporting intimate health, and even influencing your mental well-being.
aguulp for biome strains:
Lactobacillus acidophilus LA85
Lactobacillus acidophilus is the main probiotic in the small intestine and is the most widely researched and proven strain of probiotic bacteria.
- Supports Immune function: plays an important role in regulating intestinal immune activity, enhancing the immune response in the body. This strain has also been shown to help reduce allergy symptoms.
- Helps maintain the integrity of the intestinal lining: shown to promote intestinal mucosal repair, helping to improve gut barrier function and improve symptoms of leaky gut.
- Helps aid digestion and prevent diarrhoea: shown to be effective for the treatment of bacterial overgrowth, chronic diarrhoea and antibiotic associated diarrhoea.
Lactobacillus reuteri LR08
Lactobacillus reuteri is a species of bacteria that has been well studied and has been shown to be particularly helpful in women and children’s health. It has also been shown to be effective against diarrhoea, and infections which are often associated with stomach ulcers.
- Production of antimicrobial molecules: renowned for its ability to produce an antimicrobial compound known as reuterin, which helps to inhibit the growth of pathogenic bacteria, fungi and viruses within the gut.
- Production of nutrients: shown to be particularly useful in the production of important nutrients including folate and vitamin B12.
- Oral Health: helpful in promoting oral health and specifically in fighting gum disease (also known as gingivitis).
Lactobacillus casei LC89
The Lactobacillus casei species have been developed and studied by food and health scientists and are often used to ferment foods such as cheese and yoghurts due to its ability to adapt and survive a wide range of temperatures and pH levels. Strains of this species are very well documented and are widely used in probiotic formulations due the reported health benefits, specifically in relation to immune health and digestive health.
- Production of antimicrobial substances: fights harmful bacteria, including those resistant to antibiotics. This helps promote the growth of beneficial microbes and keeps the gut in balance. (Ullah N. et al., 2017).
- Enhances gut barrier function: shown to provide a protective effect against alterations and impairments of gut barrier function.
- Reduces the adhesion of pathogens: helps to inhibit the growth of harmful pathogens within the gut by competing for space and adhering to intestinal surfaces on the gut lining. This helps support the growth of beneficial microbes within the gut.
- Modulation of the immune system: supports the immune system by increasing the activity of important immune cells that fight against infections and disease, and by altering the composition of gut bacteria.
Lactobacillus gasseri LG08
Gasseri is one of the many lactobacillus strains of bacteria living inside the human body, and is specifically found in the vaginal flora.
- Weight loss: believed to play a direct role in weight loss, attributed to improved blood sugar regulation and hormone sensitivity, which in turn can help to reduce body fat, according to studies.
- IBS (D): There is some research that may suggest this strain improves diarrhoea dominant IBS symptoms including abdominal pain, distension and disturbances to daily life.
Lactobacillus plantarum Lp90
Plantarum has the ability to produce its own antibiotic, effectively combating harmful bacteria. This versatile species is found and isolated from various sources, including saliva, the human intestine, dairy products, plant material, and silage. Moreover, L. Plantarum strains play a significant role in fermenting a variety of foods like sauerkraut, pickles, and sourdough bread.
- Improving IBS: may be effective in relieving symptoms of IBS including abdominal pain and bloating.
- Skin health: shown to be beneficial in improving symptoms of dermatitis (eczema) in children.
- Heart health: may protect cardiovascular health in postmenopausal women with metabolic syndrome.
Lactobacillus rhamnosus LRa05
Lactobacillus rhamnosus is a type of bacteria that produces the enzyme known as lactase. This enzyme breaks down the sugar found in dairy products (lactose) into lactic acid, a substance which helps to inhibit the growth of harmful bacteria in the gut. It is a widely researched strain and is reported to have a number of health benefits.
- May prevent and treat diarrhoea: May help prevent or treat various types of diarrhoea, according to studies
- IBS relief: this particular species of bacteria may strengthen gut barrier function, which in turn may help relieve IBS symptoms, according to research
- Overall gut health: According to studies, this strain can prevent the overgrowth of Candida albicans (a type of harmful yeast when allowed to proliferate) in the intestines. It can also help increase the production of short-chain fatty acids (SCFAs) which are thought to exert anti-inflammatory effects and act as a food source to other healthy bacteria, further encouraging a healthy microbiome.
Bifidobacterium lactis BLa80
Bifidobacterium lactis is also known as Bifidobacterium animalis subsp. It can be found in the large intestines. The role of this particular species of bacteria is to break down body waste and aid in the absorption of various vitamins & minerals.
- Improves cholesterol: Probiotics, including this one, may help reduce cholesterol through various mechanisms, such as assimilation, binding of cholesterol in the body, and the production of short-chain fatty acids.
- Enhances immunity: dietary consumption has been shown to enhance natural immunity in studies. This strain plays a role in regulating immune system activity toward harmful bacteria and pathogens.
- Improves digestive conditions: can contribute to the relief of many gut related disorders such as maintaining intestinal barrier function. It has also been shown to be beneficial for reducing incidents of diarrhoea and improvements in bowel frequency in constipation.
Bifidobacterium longum BL21
B longum has been extensively studied and is believed to offer a number of health benefits, mainly in relation to gut health.
- Irritable Bowel Disease (IBD): according to initial animal studies, it has shown potential for being effective for relieving and treating the symptoms of inflammatory bowel diseases, such as Ulcerative Colitis.
- Irritable Bowel Syndrome (IBS): research suggests that strains may reduce gastrointestinal symptom severity and improve the psychological well-being of individuals with certain IBS subtypes.
- General gut Health: strains have been shown to help eliminate toxic producing bacterial strains (known as ETBF) which are strongly associated with inflammation and diarrhoea.
Bifidobacterium bifidum BBi32
Bifidum is the most common probiotic bacteria found in the human body. The probiotic is present in high amounts in the colon, the lower small intestine and in breast milk.
- Helps fight candida overgrowth: known to directly compete with candida and other types of yeast in our bodies, this is helpful in reducing proliferation of candida in the body. According to research, candida infections are commonly associated with low concentrations of this bacteria.
- Immune support: shown to help regulate immunological and inflammatory responses in the human body.
- Irritable Bowel Syndrome: shown to effectively alleviate symptoms of IBS.
Streptococcus thermophilus ST81
Streptococcus Thermophilus is a powerful probiotic strain that has well researched health benefits. This probiotic is used for culturing many dairy products including cheese and yoghurt.
- Immunity: regulates the immune response and inflammation, according to studies.
- Lactose Intolerance: improves lactose digestion in the gastrointestinal tract and reduces the symptoms of lactose intolerance, according to a study on mice.
- Antimicrobial activity: thought to exert antimicrobial activity against harmful bacteria, inhibiting the growth of these undesirable bacteria in the gut.
- Oral Health: inhibited the growth of bacteria and emission of compounds that are associated with gingivitis and contribute to bad breath, according to studies.
If you’re looking to jumpstart your gut and optimise not only your digestive health but your overall health too, try our new and improved aguulp for biome probiotic supplement. Packed with 10 different probiotic strains – 50 billion in total, plus prebiotics (plant fibres that feed the probiotics) too, ensuring the bacteria thrive and survive in your gut microbiome.
*Not all the benefits listed carry approved health claims. This product is not intended to diagnose, treat, cure or prevent any disease.
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506-14. doi: 10.1038/nrgastro.2014.66. Epub 2014 Jun 10. PMID: 24912386.
Markowiak P and Śliżewska K (2017) Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients, 9(9): 1021
Magnúsdóttir S, Ravcheev D, de Crécy-Lagard V, Thiele I (2015) Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes. Frontiers in Genetics, 6, 148
O’ Kennedy D (2016) B Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review. Nutrients, 8(2): 68
Rodríguez-Olleros C, Curiel MD (2019) Vitamin K and Bone Health: A Review on the Effects of Vitamin K Deficiency and Supplementation and the Effect of Non-Vitamin K Antagonist Oral Anticoagulants on Different Bone Parameters. Journal of Osteoporosis, Article ID 2069176
Iyer, R., Tomar, S.K., Maheswari, T.U. and Singh, R., 2010. Streptococcus thermophilus strains: Multifunctional lactic acid bacteria. International Dairy Journal, 20(3), pp.133-141.
Streptococcus thermophilus: from yogurt starter to new promising probiotic candidate? J Fun Foods 2017 Oct;37:74-89.
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2010. Scientific Opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to Article 13 (1) of Regulation (EC) No 1924/2006. EFSA Journal, 8(10), p.1763.
Xue L, Li Z, Xue J, Wang H, Wu T, Liu R, Sui W, Zhang M. Lactobacillus acidophilus LA85 ameliorates cyclophosphamide-induced immunosuppression by modulating Notch and TLR4/NF-κB signal pathways and remodeling the gut microbiota. Food Funct. 2022 Aug 1;13(15):8107-8118. doi: 10.1039/d1fo04331e. PMID: 35793105.
De Simone C, Ciardi A, Grassi A, Lambert Gardini S, Tzantzoglou S, Trinchieri V, Moretti S, Jirillo E. Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes. Immunopharmacol Immunotoxicol. 1992;14(1-2):331-40. doi: 10.3109/08923979209009228. PMID: 1597660.
Tegegne BA, Kebede B. Probiotics, their prophylactic and therapeutic applications in human health development: A review of the literature. Heliyon. 2022 Jun 22;8(6):e09725. doi: 10.1016/j.heliyon.2022.e09725. PMID: 35785237; PMCID: PMC9240980.
Beausoleil M, Fortier N, Guénette S, L’ecuyer A, Savoie M, Franco M, Lachaine J, Weiss K. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol. 2007 Nov;21(11):732-6. doi: 10.1155/2007/720205. PMID: 18026577; PMCID: PMC2658588.
Gaon D, Garmendia C, Murrielo NO, de Cucco Games A, Cerchio A, Quintas R, González SN, Oliver G. Effect of Lactobacillus strains (L. casei and L. Acidophillus Strains cerela) on bacterial overgrowth-related chronic diarrhea. Medicina (B Aires). 2002;62(2):159-63. PMID: 12038039.
Jones, S.E. & Versalovic, J., (2009), ‘Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors.’ BMC Microbiology, 9:35.
Lee Y. and Salminen S., (2009), Handbook of Probiotic and Prebiotics. 2nd edition, Hoboken: John Wiley & Sons.
Morita H. et al., (2008), ‘Comparative Genome Analysis of Lactobacillus reuteri and Lactobacillus fermentum Reveal a Genomic Island for Reuterin and Cobalamin Producion’ DNA Research, 15:151-161.
Qinghui Mu, Vincent J. Tavella and Xin M. Luo*. (2018). Role of Lactobacillus reuteri in Human Health and Diseases. Front. Microbiol.,. 2 (1), 227-3.
Santos F. et al., (2008), ‘High-Level Folate Production in Fermented Foods by the B12 Producer Lactobacillus reuteri JCM1112’. Applied and Environmental Microbiology. 74:10.
Talarico T.L. & Dobrogosz W.J., (1989), ‘Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri’. Antimicrob. Agents Chemother., 33(5):674-9.
Zheng J, Wittouck S. et al., (2020) ‘A taxonmonic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae’. Int.J.Syst.Evol.Microbiol, 70(4): 2782-2858. DOI: 10.1099/ijsem.0.004107
Krasse P, Carlsson B, Dahl C, et al. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swedish Dental Journal. 2006 ;30(2):55-60. PMID: 16878680.
M. Gobbetti, F. Minervini, (2014). Encyclopedia of Food Microbiology (Second Edition). 2nd ed. USA: Academic Press. 432-438.
Y.-K. Lee and K.-Y. Puong. (2007). Competition for adhesion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate. British Journal of Nutrition. 88 (1), S101–S108.
Holzapfel W.H. et al., (2001), ‘Taxonomy and important features of probiotic microorganisms in food and nutrition’. The American Journal of Clinical Nutrition, 73:365S-373S.
Reale M, et al., (2011), ‘Daily Lactobacillus casei Shirota intake increases natural killer cell activity in smokers’. British Journal of Nutrition, 108(2):308-314.
Dong Soo Han, Gyomoon-Dong, Guri-Si, Gyeonggi-Do. (2010). Lactobacillus casei prevents impaired barrier function in intestinal epithelial cells. Journal of pathology, microbiology, and immunology. 4 (7), 471-701.
Niamat Ullah, Xuejiao Wanga, Jin Wua Yan Guo, Hanjing Gec, Tengyu Lia, Saleem Khan, Zhixi Li, Xianchao Feng . (2017). Purification and primary characterization of a novel bacteriocin, LiN333, from Lactobacillus casei, an isolate from a Chinese fermented food. LWT. 84 (5), 867-875.
Kim J, Yun JM, Kim MK, Kwon O, Cho B. Lactobacillus gasseri BNR17 Supplementation Reduces the Visceral Fat Accumulation and Waist Circumference in Obese Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. J Med Food. 2018 May;21(5):454-461. doi: 10.1089/jmf.2017.3937. Epub 2018 Apr 24. PMID: 29688793.
Shin SP, Choi YM, Kim WH, Hong SP, Park JM, Kim J, Kwon O, Lee EH, Hahm KB. A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome. J Clin Biochem Nutr. 2018 Mar;62(2):179-186. doi: 10.3164/jcbn.17-73. Epub 2018 Jan 11. PMID: 29610559; PMCID: PMC5874236.
Ducrotté P, Sawant P, Jayanthi V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J Gastroenterol 2012; 18(30): 4012-4018
Barreto FM, Colado Simão AN, Morimoto HK, Batisti Lozovoy MA, Dichi I, Helena da Silva Miglioranza L. Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome. Nutrition. 2014;30(7-8):939-942. doi:10.1016/j.nut.2013.12.004
Han Y, Kim B, Ban J, Lee J, Kim BJ, Choi BS, Hwang S, Ahn K, Kim J. A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis. Pediatr Allergy Immunol. 2012 Nov;23(7):667-73. doi: 10.1111/pai.12010. Epub 2012 Oct 11. PMID: 23050557.
Evans M, Salewski RP, Christman MC, Girard SA, Tompkins TA. Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2016 Jul;116(1):94-103. doi: 10.1017/S0007114516001665. Epub 2016 May 12. PMID: 27169634.
Ruszczyński M, Radzikowski A, Szajewska H. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharmacol Ther. 2008 Jul;28(1):154-61. doi: 10.1111/j.1365-2036.2008.03714.x. Epub 2008 Apr 13. PMID: 18410562.
Basu S, Paul DK, Ganguly S, Chatterjee M, Chandra PK. Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: a randomized controlled trial. J Clin Gastroenterol. 2009 Mar;43(3):208-13. doi: 10.1097/MCG.0b013e31815a5780. PMID: 18813028.
Bae JM. Prophylactic efficacy of probiotics on travelers’ diarrhea: an adaptive meta-analysis of randomized controlled trials. Epidemiol Health. 2018;40:e2018043. doi: 10.4178/epih.e2018043. Epub 2018 Aug 29. PMID: 30189723; PMCID: PMC6232657.
Guarino A, Guandalini S, Lo Vecchio A. Probiotics for Prevention and Treatment of Diarrhea. J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S37-45. doi: 10.1097/MCG.0000000000000349. PMID: 26447963.
Verdenelli MC, Ghelfi F, Silvi S, Orpianesi C, Cecchini C, Cresci A. Probiotic properties of Lactobacillus rhamnosus and Lactobacillus paracasei isolated from human faeces. Eur J Nutr. 2009 Sep;48(6):355-63. doi: 10.1007/s00394-009-0021-2. Epub 2009 Apr 14. PMID: 19365593.
Joost Flach, M.B. van der Waal, A.F.M. Kardinaal, J. Schloesser, R.M.A.J. Ruijschop & E. Claassen | Fatih Yildiz (Reviewing Editor) (2018) Probiotic research priorities for the healthy adult population: A review on the health benefits of Lactobacillus rhamnosus GG and Bifidobacterium animalis subspecies lactis BB-12, Cogent Food & Agriculture, 4:1, DOI: 10.1080/23311932.2018.1452839
LeBlanc JG, Chain F, Martín R, Bermúdez-Humarán LG, Courau S, Langella P. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb Cell Fact. 2017 May 8;16(1):79. doi: 10.1186/s12934-017-0691-z. PMID: 28482838; PMCID: PMC5423028.
Grin PM, Kowalewska PM, Alhazzan W, Fox-Robichaud AE. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Can J Urol. 2013 Feb;20(1):6607-14. PMID: 23433130.
Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr. 2000 Mar;54(3):263-7. doi: 10.1038/sj.ejcn.1600938. PMID: 10713750.
Chiang BL, Sheih YH, Wang LH, Liao CK, Gill HS. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur J Clin Nutr. 2000 Nov;54(11):849-55. doi: 10.1038/sj.ejcn.1601093. PMID: 11114680.
Fernández-Calderón MC, Sánchez-Moro MDH, Rincón EO. In vitro Cholesterol Assimilation by Bifidobacterium animalis subsp. lactis (BPL1) Probiotic Bacteria Under Intestinal Conditions. Endocr Metab Immune Disord Drug Targets. 2022;22(4):433-439. doi: 10.2174/1871530321666210908124848. PMID: 34496737.
Marras L, Caputo M, Bisicchia S, Soato M, Bertolino G, Vaccaro S, Inturri R. The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia. Microorganisms. 2021 Apr 14;9(4):836. doi: 10.3390/microorganisms9040836. PMID: 33919907; PMCID: PMC8070932.
Kumar M, Nagpal R, Kumar R, Hemalatha R, Verma V, Kumar A, Chakraborty C, Singh B, Marotta F, Jain S, Yadav H. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res. 2012;2012:902917. doi: 10.1155/2012/902917. Epub 2012 May 3. Erratum in: J Diabetes Res. 2022 Apr 1;2022:3952529. PMID: 22611376; PMCID: PMC3352670.
Cheng J, Laitila A, Ouwehand AC. Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review. Front Nutr. 2021 Dec 14;8:790561. doi: 10.3389/fnut.2021.790561. PMID: 34970580; PMCID: PMC8712437.
Yao S, Zhao Z, Wang W, Liu X. Bifidobacterium Longum: Protection against Inflammatory Bowel Disease. J Immunol Res. 2021 Jul 23;2021:8030297. doi: 10.1155/2021/8030297. PMID: 34337079; PMCID: PMC8324359.
Lewis ED, Antony JM, Crowley DC, Piano A, Bhardwaj R, Tompkins TA, Evans M. Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in Alleviating Symptoms of Irritable Bowel Syndrome (IBS): A Randomized, Placebo-Controlled Study. Nutrients. 2020 Apr 21;12(4):1159. doi: 10.3390/nu12041159. PMID: 32326347; PMCID: PMC7230591.
Odamaki T, Sugahara H, Yonezawa S, Yaeshima T, Iwatsuki K, Tanabe S, Tominaga T, Togashi H, Benno Y, Xiao JZ. Effect of the oral intake of yogurt containing Bifidobacterium longum BB536 on the cell numbers of enterotoxigenic Bacteroides fragilis in microbiota. Anaerobe. 2012 Feb;18(1):14-8. doi: 10.1016/j.anaerobe.2011.11.004. Epub 2011 Nov 26. PMID: 22138361.
Liviana Ricci and others, Human gut bifidobacteria inhibit the growth of the opportunistic fungal pathogen Candida albicans, FEMS Microbiology Ecology, Volume 98, Issue 10, October 2022, fiac095, https://doi.org/10.1093/femsec/fiac095
Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life–a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011 May;33(10):1123-32. doi: 10.1111/j.1365-2036.2011.04633.x. Epub 2011 Mar 21. PMID: 21418261.
Iyer R., Tomar S.K., Kapila S., Mani J., Singh R. Probiotic Properties of Folate Producing Streptococcus thermophilus Strains. Food Res. Int. 2010;43:103–110. doi: 10.1016/j.foodres.2009.09.011
Ogita T, Tanii Y, Morita H, Suzuki T, Tanabe S. Suppression of Th17 response by Streptococcus thermophilus ST28 through induction of IFN-γ. Int J Mol Med. 2011 Nov;28(5):817-22. doi: 10.3892/ijmm.2011.755. Epub 2011 Jul 20. PMID: 21887477.
Lee SH, Baek DH. Effects of Streptococcus thermophilus on volatile sulfur compounds produced by Porphyromonas gingivalis. Arch Oral Biol. 2014 Nov;59(11):1205-10. doi: 10.1016/j.archoralbio.2014.07.006. Epub 2014 Jul 24. PMID: 25105253.
Corrêa NB, Péret Filho LA, Penna FJ, Lima FM, Nicoli JR. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J Clin Gastroenterol. 2005 May-Jun;39(5):385-9.
Di Marzio L, Centi C, Cinque B, Masci S, Giuliani M, Arcieri A, Zicari L, De Simone C, Cifone MG. Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp Dermatol. 2003 Oct;12(5):615-20.
Jain PK, McNaught CE, Anderson AD, MacFie J, Mitchell CJ. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr. 2004 Aug;23(4):467-75.
Mater DD, Bretigny L, Firmesse O, Flores MJ, Mogenet A, Bresson JL, Corthier G. Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt. FEMS Microbiol Lett. 2005 Sep 15;250(2):185-7.
Nopchinda S, Varavithya W, Phuapradit P, Sangchai R, Suthutvoravut U, Chantraruksa V, Haschke F. Effect of bifidobacterium Bb12 with or without Streptococcus thermophilus supplemented formula on nutritional status. J Med Assoc Thai. 2002 Nov;85 Suppl 4:S1225-31.
Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet. 1994 Oct 15;344(8929):1046-9.
Thibault H, Aubert-Jacquin C, Goulet O. Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr. 2004 Aug;39(2):147-52.